Literature DB >> 16455641

Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study.

Fatiha Maskali1, Philippe R Franken, Sylvain Poussier, Nguyen Tran, Chris Vanhove, Henri Boutley, Hervé Le Gall, Gilles Karcher, Faïez Zannad, Patrick Lacolley, Pierre Y Marie.   

Abstract

UNLABELLED: The rat infarct model is widely used to study left ventricular (LV) remodeling, a main cause of heart failure characterized by progressive LV dilatation. Using pinhole collimators and advances in data processing, gated SPECT was recently adapted to image the rat heart. The aim of this study was to assess this new imaging technique for predicting and quantifying variable LV remodeling from the rat infarct model.
METHODS: Pinhole 99mTc-sestamibi gated SPECT was validated for determining LV volume and identifying the necrotic and nonviable LV segments (<50% of 99mTc-sestamibi uptake) in rats, and it was applied to monitor rat LV function from 48 h to 12 wk after occlusion of the left anterior descending coronary artery (LAD) (n = 20) or sham operation (n = 9).
RESULTS: In LAD-occluded rats, 48-h SPECT necrosis was large (> or =30% LV) in 6, limited (<30% LV) in 6, and undetectable in 8. End-diastolic volume of LAD-occluded rats was equivalent to that of sham-operated rats at 48 h (320 +/- 84 microL vs. 293 +/- 48 microL; not significant) but became higher at 12 wk (501 +/- 191 microL vs. 343 +/- 46 microL; P = 0.01). The follow-up increase in end-diastolic volume, which reflects the remodeling process, was closely related to the initial extent of necrosis revealed by the SPECT images (P < 0.001; R2= 0.85). This increase was limited in sham-operated rats (50 +/- 15 microL) and in the LAD-occluded rats with undetectable necrosis (55 +/- 35 microL) but it was around 3- and 7-fold higher in the LAD-occluded rats with limited (165 +/- 57 microL) and large (366 +/- 113 microL) necrosis, respectively.
CONCLUSION: The variable LV remodeling documented after coronary occlusion in rats closely relates to the variable extent of necrosis provided by this model. Pinhole gated SPECT allows this remodeling to be predicted and quantified and, hence, constitutes an original tool for the experiments scheduled on the rat infarct model.

Entities:  

Mesh:

Year:  2006        PMID: 16455641

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

Review 1.  Monitoring left ventricular function in small animals.

Authors:  Tony Lahoutte
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

2.  Acipimox-enhanced ¹⁸F-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model.

Authors:  Mélanie Bousquenaud; Fatiha Maskali; Sylvain Poussier; Pierre-Yves Marie; Henri Boutley; Gilles Karcher; Daniel R Wagner; Yvan Devaux
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-25       Impact factor: 2.357

3.  ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.

Authors:  Sylvain Poussier; Fatiha Maskali; Nguyen Tran; Christophe Person; Pablo Maureira; Henri Boutley; Gilles Karcher; Patrick Lacolley; Véronique Régnault; Renaud Fay; Pierre Yves Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

4.  Assessment of the early stage of cardiac remodeling of spontaneously hypertensive heart failure rats using the quantitative 3-dimensional analysis provided by acipimox-enhanced FDG-PET.

Authors:  Fatiha Maskali; Sylvain Poussier; Huguette Louis; Henri Boutley; Mickael Lhuillier; Simon N Thornton; Gilles Karcher; Patrick Lacolley; Pierre Y Marie
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-03       Impact factor: 2.357

5.  Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction.

Authors:  Zakir H Sahul; Rupak Mukherjee; James Song; Jarod McAteer; Robert E Stroud; Donald P Dione; Lawrence Staib; Xenophon Papademetris; Lawrence W Dobrucki; James S Duncan; Francis G Spinale; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2011-04-19       Impact factor: 7.792

6.  Routine evaluation of left ventricular function using CZT-SPECT, with low injected activities and limited recording times.

Authors:  Marine Claudin; Laetitia Imbert; Wassila Djaballah; Nicolas Veran; Sylvain Poussier; Véronique Roch; Mathieu Perrin; Antoine Verger; Henri Boutley; Gilles Karcher; Pierre-Yves Marie
Journal:  J Nucl Cardiol       Date:  2016-09-27       Impact factor: 5.952

7.  Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.

Authors:  Pablo Maureira; Pierre-Yves Marie; Yihua Liu; Fengxu Yu; Sylvain Poussier; Fatiha Maskali; Frederique Groubatch; Gilles Karcher; Nguyen Tran
Journal:  Int J Cardiovasc Imaging       Date:  2013-02-13       Impact factor: 2.357

8.  Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction.

Authors:  Yvan Devaux; Melanie Bousquenaud; Sophie Rodius; Pierre-Yves Marie; Fatiha Maskali; Lu Zhang; Francisco Azuaje; Daniel R Wagner
Journal:  BMC Med Genomics       Date:  2011-12-05       Impact factor: 3.063

9.  Comparison between Radionuclide Ventriculography and Echocardiography for Quantification of Left Ventricular Systolic Function in Rats Exposed to Doxorubicin.

Authors:  Luciano Fonseca Lemos de Oliveira; João Lucas O'Connell; Eduardo Elias Vieira de Carvalho; Érica Carolina Campos Pulici; Minna Moreira Dias Romano; Benedito Carlos Maciel; Marcus Vinicius Simões
Journal:  Arq Bras Cardiol       Date:  2017-01       Impact factor: 2.000

10.  Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study.

Authors:  Bernard Cosyns; Steven Droogmans; Caroline Weytjens; Tony Lahoutte; Guy Van Camp; Danny Schoors; Philippe R Franken
Journal:  Cardiovasc Diabetol       Date:  2007-10-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.